2
|
Probst G, Aubele DL, Bowers S, Dressen D, Garofalo AW, Hom RK, Konradi AW, Marugg JL, Mattson MN, Neitzel ML, Semko CM, Sham HL, Smith J, Sun M, Truong AP, Ye XM, Xu YZ, Dappen MS, Jagodzinski JJ, Keim PS, Peterson B, Latimer LH, Quincy D, Wu J, Goldbach E, Ness DK, Quinn KP, Sauer JM, Wong K, Zhang H, Zmolek W, Brigham EF, Kholodenko D, Hu K, Kwong GT, Lee M, Liao A, Motter RN, Sacayon P, Santiago P, Willits C, Bard F, Bova MP, Hemphill SS, Nguyen L, Ruslim L, Tanaka K, Tanaka P, Wallace W, Yednock TA, Basi GS. Discovery of (R)-4-Cyclopropyl-7,8-difluoro-5-(4-(trifluoromethyl)phenylsulfonyl)-4,5-dihydro-1H-pyrazolo[4,3-c]quinoline (ELND006) and (R)-4-Cyclopropyl-8-fluoro-5-(6-(trifluoromethyl)pyridin-3-ylsulfonyl)-4,5-dihydro-2H-pyrazolo[4,3-c]quinoline (ELND007): Metabolically Stable γ-Secretase Inhibitors that Selectively Inhibit the Production of Amyloid-β over Notch. J Med Chem 2013; 56:5261-74. [DOI: 10.1021/jm301741t] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
Affiliation(s)
- Gary Probst
- Department of Medicinal
Chemistry, Elan Pharmaceuticals, 180 Oyster
Point Boulevard, South San Francisco, California 94080, United States
| | - Danielle L. Aubele
- Department of Medicinal
Chemistry, Elan Pharmaceuticals, 180 Oyster
Point Boulevard, South San Francisco, California 94080, United States
| | - Simeon Bowers
- Department of Medicinal
Chemistry, Elan Pharmaceuticals, 180 Oyster
Point Boulevard, South San Francisco, California 94080, United States
| | - Darren Dressen
- Department of Medicinal
Chemistry, Elan Pharmaceuticals, 180 Oyster
Point Boulevard, South San Francisco, California 94080, United States
| | - Albert W. Garofalo
- Department of Medicinal
Chemistry, Elan Pharmaceuticals, 180 Oyster
Point Boulevard, South San Francisco, California 94080, United States
| | - Roy K. Hom
- Department of Medicinal
Chemistry, Elan Pharmaceuticals, 180 Oyster
Point Boulevard, South San Francisco, California 94080, United States
| | - Andrei W. Konradi
- Department of Medicinal
Chemistry, Elan Pharmaceuticals, 180 Oyster
Point Boulevard, South San Francisco, California 94080, United States
| | - Jennifer L. Marugg
- Department of Medicinal
Chemistry, Elan Pharmaceuticals, 180 Oyster
Point Boulevard, South San Francisco, California 94080, United States
| | - Matthew N. Mattson
- Department of Medicinal
Chemistry, Elan Pharmaceuticals, 180 Oyster
Point Boulevard, South San Francisco, California 94080, United States
| | - Martin L. Neitzel
- Department of Medicinal
Chemistry, Elan Pharmaceuticals, 180 Oyster
Point Boulevard, South San Francisco, California 94080, United States
| | - Chris M. Semko
- Department of Medicinal
Chemistry, Elan Pharmaceuticals, 180 Oyster
Point Boulevard, South San Francisco, California 94080, United States
| | - Hing L. Sham
- Department of Medicinal
Chemistry, Elan Pharmaceuticals, 180 Oyster
Point Boulevard, South San Francisco, California 94080, United States
- Department of Process and Analytical
Chemistry, Elan Pharmaceuticals, 180 Oyster
Point Boulevard, South San Francisco, California 94080, United States
| | - Jenifer Smith
- Department of Medicinal
Chemistry, Elan Pharmaceuticals, 180 Oyster
Point Boulevard, South San Francisco, California 94080, United States
| | - Minghua Sun
- Department of Medicinal
Chemistry, Elan Pharmaceuticals, 180 Oyster
Point Boulevard, South San Francisco, California 94080, United States
| | - Anh P. Truong
- Department of Medicinal
Chemistry, Elan Pharmaceuticals, 180 Oyster
Point Boulevard, South San Francisco, California 94080, United States
| | - Xiaocong M. Ye
- Department of Medicinal
Chemistry, Elan Pharmaceuticals, 180 Oyster
Point Boulevard, South San Francisco, California 94080, United States
| | - Ying-zi Xu
- Department of Medicinal
Chemistry, Elan Pharmaceuticals, 180 Oyster
Point Boulevard, South San Francisco, California 94080, United States
| | - Michael S. Dappen
- Department of Process and Analytical
Chemistry, Elan Pharmaceuticals, 180 Oyster
Point Boulevard, South San Francisco, California 94080, United States
| | - Jacek J. Jagodzinski
- Department of Process and Analytical
Chemistry, Elan Pharmaceuticals, 180 Oyster
Point Boulevard, South San Francisco, California 94080, United States
| | - Pamela S. Keim
- Department of Process and Analytical
Chemistry, Elan Pharmaceuticals, 180 Oyster
Point Boulevard, South San Francisco, California 94080, United States
| | - Brian Peterson
- Department of Process and Analytical
Chemistry, Elan Pharmaceuticals, 180 Oyster
Point Boulevard, South San Francisco, California 94080, United States
| | - Lee H. Latimer
- Department of Process and Analytical
Chemistry, Elan Pharmaceuticals, 180 Oyster
Point Boulevard, South San Francisco, California 94080, United States
| | - David Quincy
- Department of Process and Analytical
Chemistry, Elan Pharmaceuticals, 180 Oyster
Point Boulevard, South San Francisco, California 94080, United States
| | - Jing Wu
- Department of Process and Analytical
Chemistry, Elan Pharmaceuticals, 180 Oyster
Point Boulevard, South San Francisco, California 94080, United States
| | - Erich Goldbach
- Department of Lead Finding, Drug
Disposition, and Safety Evaluation, Elan Pharmaceuticals, 180 Oyster Point Boulevard, South San Francisco, California 94080,
United States
| | - Daniel K. Ness
- Department of Lead Finding, Drug
Disposition, and Safety Evaluation, Elan Pharmaceuticals, 180 Oyster Point Boulevard, South San Francisco, California 94080,
United States
| | - Kevin P. Quinn
- Department of Lead Finding, Drug
Disposition, and Safety Evaluation, Elan Pharmaceuticals, 180 Oyster Point Boulevard, South San Francisco, California 94080,
United States
| | - John-Michael Sauer
- Department of Lead Finding, Drug
Disposition, and Safety Evaluation, Elan Pharmaceuticals, 180 Oyster Point Boulevard, South San Francisco, California 94080,
United States
| | - Karina Wong
- Department of Lead Finding, Drug
Disposition, and Safety Evaluation, Elan Pharmaceuticals, 180 Oyster Point Boulevard, South San Francisco, California 94080,
United States
| | - Hongbin Zhang
- Department of Lead Finding, Drug
Disposition, and Safety Evaluation, Elan Pharmaceuticals, 180 Oyster Point Boulevard, South San Francisco, California 94080,
United States
| | - Wes Zmolek
- Department of Lead Finding, Drug
Disposition, and Safety Evaluation, Elan Pharmaceuticals, 180 Oyster Point Boulevard, South San Francisco, California 94080,
United States
| | - Elizabeth F. Brigham
- Department
of In Vivo Pharmacology, Elan Pharmaceuticals, 180 Oyster Point Boulevard, South San Francisco, California 94080,
United States
| | - Dora Kholodenko
- Department
of In Vivo Pharmacology, Elan Pharmaceuticals, 180 Oyster Point Boulevard, South San Francisco, California 94080,
United States
| | - Kang Hu
- Department
of In Vivo Pharmacology, Elan Pharmaceuticals, 180 Oyster Point Boulevard, South San Francisco, California 94080,
United States
| | - Grace T. Kwong
- Department
of In Vivo Pharmacology, Elan Pharmaceuticals, 180 Oyster Point Boulevard, South San Francisco, California 94080,
United States
| | - Michael Lee
- Department
of In Vivo Pharmacology, Elan Pharmaceuticals, 180 Oyster Point Boulevard, South San Francisco, California 94080,
United States
| | - Anna Liao
- Department
of In Vivo Pharmacology, Elan Pharmaceuticals, 180 Oyster Point Boulevard, South San Francisco, California 94080,
United States
| | - Ruth N. Motter
- Department
of In Vivo Pharmacology, Elan Pharmaceuticals, 180 Oyster Point Boulevard, South San Francisco, California 94080,
United States
| | - Patricia Sacayon
- Department
of In Vivo Pharmacology, Elan Pharmaceuticals, 180 Oyster Point Boulevard, South San Francisco, California 94080,
United States
| | - Pamela Santiago
- Department
of In Vivo Pharmacology, Elan Pharmaceuticals, 180 Oyster Point Boulevard, South San Francisco, California 94080,
United States
| | - Christopher Willits
- Department
of In Vivo Pharmacology, Elan Pharmaceuticals, 180 Oyster Point Boulevard, South San Francisco, California 94080,
United States
| | - Frédérique Bard
- Department
of Biology, Elan Pharmaceuticals, 180 Oyster
Point Boulevard, South San Francisco, California 94080, United States
| | - Michael P. Bova
- Department
of Biology, Elan Pharmaceuticals, 180 Oyster
Point Boulevard, South San Francisco, California 94080, United States
| | - Susanna S. Hemphill
- Department
of Biology, Elan Pharmaceuticals, 180 Oyster
Point Boulevard, South San Francisco, California 94080, United States
| | - Lam Nguyen
- Department
of Biology, Elan Pharmaceuticals, 180 Oyster
Point Boulevard, South San Francisco, California 94080, United States
| | - Lany Ruslim
- Department
of Biology, Elan Pharmaceuticals, 180 Oyster
Point Boulevard, South San Francisco, California 94080, United States
| | - Kevin Tanaka
- Department
of Biology, Elan Pharmaceuticals, 180 Oyster
Point Boulevard, South San Francisco, California 94080, United States
| | - Pearl Tanaka
- Department
of Biology, Elan Pharmaceuticals, 180 Oyster
Point Boulevard, South San Francisco, California 94080, United States
| | - William Wallace
- Department
of Biology, Elan Pharmaceuticals, 180 Oyster
Point Boulevard, South San Francisco, California 94080, United States
| | - Ted A. Yednock
- Department of Medicinal
Chemistry, Elan Pharmaceuticals, 180 Oyster
Point Boulevard, South San Francisco, California 94080, United States
- Department of Process and Analytical
Chemistry, Elan Pharmaceuticals, 180 Oyster
Point Boulevard, South San Francisco, California 94080, United States
- Department of Lead Finding, Drug
Disposition, and Safety Evaluation, Elan Pharmaceuticals, 180 Oyster Point Boulevard, South San Francisco, California 94080,
United States
- Department
of In Vivo Pharmacology, Elan Pharmaceuticals, 180 Oyster Point Boulevard, South San Francisco, California 94080,
United States
- Department
of Biology, Elan Pharmaceuticals, 180 Oyster
Point Boulevard, South San Francisco, California 94080, United States
| | - Guriqbal S. Basi
- Department
of Biology, Elan Pharmaceuticals, 180 Oyster
Point Boulevard, South San Francisco, California 94080, United States
| |
Collapse
|